Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects

Clinica Chimica Acta

Volumn 321, Issue 1-2, 2002, Pages 107-112

  Kobayashi, Junji ^a   Katsube, Susumu ^a   Shimoda, Mayumi ^a   Furuhashi, Kenji ^a   Kitano, Shouichi ^b   Masuda, Mizue ^a   Maruyama, Tokiko ^a   Shinomiya, Masaki ^a  

^a Chibaken Saiseikai Narashino Hospital   (Japan)

^b SRL INC   (Japan)

Author keywords

C reactive protein (CRP); Familial hypercholesterolemia; LDL apheresis; Malondialdehyde modified LDL (MDA LDL); Remnant like particle cholesterol (RLP C)

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CELLULOSE; DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATEX; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MONOCLONAL ANTIBODY;

ACHILLES TENDON; ADSORPTION CHROMATOGRAPHY; ADULT; ANTIBODY AFFINITY; APHERESIS; ARTICLE; BIOASSAY; BODY MASS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HUMAN; JAPAN; MALE; PRIORITY JOURNAL; REDUCTION; REVERSED PHASE LIQUID CHROMATOGRAPHY; SERUM; STEADY STATE;

APOLIPOPROTEINS; BLOOD COMPONENT REMOVAL; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; FEMALE; FIBRINOGEN; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; JAPAN; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0036264341     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00103-1     Document Type: Article

References (34)

1. Familial hypercholesterolemia
2. Long term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL receptor proline 664 to Leucine mutation
3. For the Hokuriku-FH-LDL-apheresis Study Group. Long-term efficacy of low density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-Apheresis Study Group
4. Safety and effectiveness of long term LDL-apheresis in patients at high risk
5. LDL-Apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
6. Remnant lipoprotein concentrations in fasting serum predict coronary events in patients with coronary artery disease
7. Lipoprotein remnant cholesterol and triglycerides values in coronary cases and Framingham controls
8. Elevation of C-reactive protein in active coronary artery disease
9. Prognostic influence of increased fibrinogen and C-reactive protein concentrations in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease
10. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
11. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes
12. Beyond cholesterol: Modification of low-density lipoprotein that increases its atherogenicity
13. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
14. Role of oxidized low density lipoprotein in atherogenicity
15. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum
16. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease
17. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
18. Cause of death in patients with familial hypercholesterolemia
19. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
20. Report of the expert committee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus
21. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia
22. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: Reference values, and age- and sex related differences
23. Homogeneous assay of serum LDL-cholesterol on an automatic analyzer
24. Evaluation of a new homogeneous assay kit for serum HDL cholesterol determinations
25. Cholesterol in remnant like lipoproteins in human serum using monoclonal anti-apoB-100 and anti-apo A-I immunoaffinity mixed gels
26. Clinical efficacy of an automated high-sensitivity C-reactive protein assay
27. Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state
28. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events
29. Triglyceride- and cholesterol-rich lipoproteins have differential effect on mid-moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin
30. Transfer of very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway
31. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implication for atherosclerosis
32. C-reactive protein and other markers of inflammation among patients undergoing LDL apheresis
33. Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
34. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages